- Home
- CMPS vs GILT Comparison
CMPS vs GILT Comparison
Compare CMPS & GILT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPS
- GILT
- Stock Information
- Founded
- CMPS 2020
- GILT 1987
- Country
- CMPS United Kingdom
- GILT Israel
- Employees
- CMPS N/A
- GILT N/A
- Industry
- CMPS Biotechnology: Pharmaceutical Preparations
- GILT Radio And Television Broadcasting And Communications Equipment
- Sector
- CMPS Health Care
- GILT Technology
- Exchange
- CMPS Nasdaq
- GILT Nasdaq
- Market Cap
- CMPS 280.2M
- GILT 334.1M
- IPO Year
- CMPS 2020
- GILT 1993
- Fundamental
- Price
- CMPS $4.03
- GILT $5.89
- Analyst Decision
- CMPS Strong Buy
- GILT Strong Buy
- Analyst Count
- CMPS 6
- GILT 2
- Target Price
- CMPS $33.60
- GILT $8.50
- AVG Volume (30 Days)
- CMPS 666.3K
- GILT 447.0K
- Earning Date
- CMPS 10-31-2024
- GILT 11-13-2024
- Dividend Yield
- CMPS N/A
- GILT N/A
- EPS Growth
- CMPS N/A
- GILT 17.04
- EPS
- CMPS N/A
- GILT 0.29
- Revenue
- CMPS N/A
- GILT $302,932,000.00
- Revenue This Year
- CMPS N/A
- GILT $18.81
- Revenue Next Year
- CMPS N/A
- GILT $32.32
- P/E Ratio
- CMPS N/A
- GILT $20.30
- Revenue Growth
- CMPS N/A
- GILT 15.14
- 52 Week Low
- CMPS $3.86
- GILT $4.04
- 52 Week High
- CMPS $12.75
- GILT $6.66
- Technical
- Relative Strength Index (RSI)
- CMPS 37.75
- GILT 54.65
- Support Level
- CMPS $3.86
- GILT $5.68
- Resistance Level
- CMPS $4.20
- GILT $6.14
- Average True Range (ATR)
- CMPS 0.29
- GILT 0.19
- MACD
- CMPS 0.00
- GILT -0.05
- Stochastic Oscillator
- CMPS 16.59
- GILT 31.82
About CMPS COMPASS Pathways Plc American Depository Shares
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find better ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.
About GILT Gilat Satellite Networks Ltd.
Gilat Satellite Networks Ltd is a provider of satellite-based broadband communications. The company designs and manufactures ground-based satellite communications equipment and provides comprehensive solutions and end-to-end services. Its portfolio includes a cloud-based satellite network platform, very small aperture terminals (VSATs), amplifiers, high-speed modems, on-the-move antennas and high-power solid-state power amplifiers (SSPAs), block-up converters (BUCs) and Transceivers. The company's solutions support multiple applications with a full portfolio of products to address key applications including broadband access, cellular backhaul, enterprise, in-flight connectivity, maritime, trains, defense, and public safety.